Purple Biotech Ltd ADR (NASDAQ:PPBT)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PPBT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PPBT

  • Market Cap$89.160m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS74638P1093

Company Profile

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.Kitov Pharma Ltd is engaged in the development of a combination drug that aims to treat osteoarthritis (OA) pain and hypertension called KIT-302 and NT219.

Latest PPBT news

Currently there for this company. Visit our news hub for other news .